{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:25:00Z","timestamp":1793863500401,"version":"4.6.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cpcardiol.2023.101715","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T20:33:48Z","timestamp":1680294828000},"page":"101715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Exploring the Underlying Mechanisms Linking Adiposity and Cardiovascular Disease: A Prospective Cohort Study of 404,332 UK Biobank Participants"],"prefix":"10.1016","volume":"48","author":[{"given":"Ziyi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Parra-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirapitcha","family":"Boonpor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Petermann-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Celis-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-9025","authenticated-orcid":false,"given":"Frederick K.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.101715_bib0001","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.metabol.2018.10.011","article-title":"Obesity and cardiovascular disease: revisiting an old relationship","volume":"92","author":"Koliaki","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.cpcardiol.2023.101715_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/535918","article-title":"Inflammation, a link between obesity and cardiovascular disease","volume":"2010","author":"Wang","year":"2010","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101715_bib0003","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurheartj\/ehz388","article-title":"Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study","volume":"41","author":"Larsson","year":"2020","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.cpcardiol.2023.101715_bib0004","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","article-title":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial","volume":"4","author":"Look","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101715_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-2005-871739","article-title":"Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction","volume":"5","author":"Douketis","year":"2005","journal-title":"Semin Vasc Med"},{"issue":"7121","key":"10.1016\/j.cpcardiol.2023.101715_bib0006","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.cpcardiol.2023.101715_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238985","article-title":"Obesity-related changes in high-density lipoprotein metabolism and function","volume":"21","author":"Stadler","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101715_bib0008","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu","year":"2017","journal-title":"Arch Med Sci"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.101715_bib0009","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrcardio.2009.55","article-title":"Obesity, inflammation, and atherosclerosis","volume":"6","author":"Rocha","year":"2009","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"10.1016\/j.cpcardiol.2023.101715_bib0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jchf.2018.09.006","article-title":"Physical activity, fitness, and obesity in heart failure with preserved ejection fraction","volume":"6","author":"Pandey","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.cpcardiol.2023.101715_bib0011","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.070371497","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide","volume":"97","author":"Tamura","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101715_bib0012","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCHEARTFAILURE.113.000885","article-title":"Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation","volume":"7","author":"Nakagawa","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101715_bib0013","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.0000112582.16683.EA","article-title":"Impact of obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cpcardiol.2023.101715_bib0014","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1210\/jc.2011-1182","article-title":"Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies","volume":"96","author":"Khan","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cpcardiol.2023.101715_bib0015","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(13)61836-X","article-title":"Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants","volume":"383","author":"Lu","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101715_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-018-0578-7","article-title":"Mediation analysis with a time-to-event outcome: a review of use and reporting in healthcare research","volume":"18","author":"Lapointe-Shaw","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.101715_bib0017","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1016\/j.orcp.2013.12.005","article-title":"Mechanisms of heart failure in obesity","volume":"8","author":"Ebong","year":"2014","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.cpcardiol.2023.101715_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101435","article-title":"Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: a prospective cohort study in the UK Biobank","volume":"48","author":"Ho","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"11","key":"10.1016\/j.cpcardiol.2023.101715_bib0019","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41591-019-0627-8","article-title":"Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease","volume":"25","author":"Lees","year":"2019","journal-title":"Nature Med"},{"issue":"22","key":"10.1016\/j.cpcardiol.2023.101715_bib0020","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.296.22.2703","article-title":"Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events","volume":"296","author":"Lange","year":"2006","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101715_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101715_bib0022","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2213-8587(21)00088-7","article-title":"Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study","volume":"9","author":"Caleyachetty","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101715_bib0023","doi-asserted-by":"crossref","first-page":"17807","DOI":"10.1038\/s41598-017-17997-5","article-title":"A prospective investigation of body size, body fat composition and colorectal cancer risk in the UK biobank","volume":"7","author":"Ortega","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101715_bib0024","doi-asserted-by":"crossref","first-page":"14541","DOI":"10.1038\/s41598-020-71302-5","article-title":"A body shape index (ABSI) achieves better mortality risk stratification than alternative indices of abdominal obesity: results from a large European cohort","volume":"10","author":"Christakoudi","year":"2020","journal-title":"Sci Rep."},{"issue":"25","key":"10.1016\/j.cpcardiol.2023.101715_bib0025","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9841","key":"10.1016\/j.cpcardiol.2023.101715_bib0026","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101715_bib0027","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12933-019-0851-z","article-title":"Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies","volume":"18","author":"Ye","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101715_bib0028","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/ije\/dyaa216","article-title":"High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease","volume":"50","author":"Zuber","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101715_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003271","article-title":"Sex-specific associations of genetically predicted circulating Lp(a) (lipoprotein(a)) and hepatic LPA gene expression levels with cardiovascular outcomes: mendelian randomization and observational analyses","volume":"14","author":"Guertin","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101715_bib0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.cpcardiol.2023.101715_bib0031","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.numecd.2009.03.021","article-title":"Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"19","author":"Mannucci","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2023.101715_bib0032","doi-asserted-by":"crossref","first-page":"38813","DOI":"10.1038\/srep38813","article-title":"Liver enzymes and risk of ischemic heart disease and type 2 diabetes mellitus: a mendelian randomization study","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101715_bib0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12916-022-02251-1","article-title":"Nonlinear causal effects of estimated glomerular filtration rate on myocardial infarction risks: mendelian randomization study","volume":"20","author":"Park","year":"2022","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101715_bib0034","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ajhg.2018.08.004","article-title":"Genetic association of albuminuria with cardiometabolic disease and blood pressure","volume":"103","author":"Haas","year":"2018","journal-title":"Am J Human Genet"},{"issue":"22","key":"10.1016\/j.cpcardiol.2023.101715_bib0035","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.296.22.2703","article-title":"Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events","volume":"296","author":"Lange","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2023.101715_bib0036","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ypmed.2016.09.003","article-title":"The effect of hematocrit and hemoglobin on the risk of ischemic heart disease: a Mendelian randomization study","volume":"91","author":"Zhong","year":"2016","journal-title":"Prev Med"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101715_bib0037","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","article-title":"Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol. A consensus statement from EAS and EFLM","volume":"64","author":"Langlois","year":"2018","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101715_bib0038","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1\u2014executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101715_bib0039","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2023.101715_bib0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.1016\/j.cpcardiol.2023.101715_bib0041","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.cpcardiol.2023.101715_bib0042","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1158\/1055-9965.EPI-19-1525","article-title":"Hematologic markers and prostate cancer risk: a prospective analysis in UK biobank","volume":"29","author":"Watts","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"10.1016\/j.cpcardiol.2023.101715_bib0043","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/hmg\/ddac022","article-title":"Corrigendum to: a genome-wide association study implicates multiple mechanisms influencing raised urinary albumin-creatinine ratio","volume":"31","author":"Casanova","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101715_bib0044","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/HYPERTENSIONAHA.119.14028","article-title":"Urinary albumin, sodium, and potassium and cardiovascular outcomes in the UK biobank: observational and mendelian randomization analyses","volume":"75","author":"Zanetti","year":"2020","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.cpcardiol.2023.101715_bib0045","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"17","key":"10.1016\/j.cpcardiol.2023.101715_bib0046","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7748\/ns.2.17.34.s66","article-title":"Health and deprivation P Townsend P Phillimore a Beattie health and deprivation published by Croom Helm 212pp pound19.95 0-7099-4351-2 [Formula: see text]","volume":"2","year":"1988","journal-title":"Nurs Stand"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.101715_bib0047","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/EDE.0000000000000160","article-title":"The parametric g-formula for time-to-event data: intuition and a worked example","volume":"25","author":"Keil","year":"2014","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101715_bib0048","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/EDE.0000000000001378","article-title":"CMAverse: a suite of functions for reproducible causal mediation analyses","volume":"32","author":"Shi","year":"2021","journal-title":"Epidemiology"},{"key":"10.1016\/j.cpcardiol.2023.101715_bib0049","first-page":"368","article-title":"Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis","author":"Batty","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101715_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/EDE.0000000000000234","article-title":"Mediators of the effect of body mass index on coronary heart disease: decomposing direct and indirect effects","volume":"26","author":"Lu","year":"2015","journal-title":"Epidemiology"},{"issue":"9771","key":"10.1016\/j.cpcardiol.2023.101715_bib0051","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(11)60105-0","article-title":"Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies","volume":"377","author":"Emerging Risk Factors","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cpcardiol.2023.101715_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128987","article-title":"Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study","volume":"10","author":"Seven","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101715_bib0053","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41366-021-00807-4","article-title":"Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis","volume":"45","author":"Gill","year":"2021","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"10.1016\/j.cpcardiol.2023.101715_bib0054","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003921","article-title":"Obesity and subtypes of incident cardiovascular disease","volume":"5","author":"Ndumele","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101715_bib0055","first-page":"101","article-title":"Methods for evaluating causality in observational studies","volume":"116","author":"Gianicolo","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.cpcardiol.2023.101715_bib0056","doi-asserted-by":"crossref","unstructured":"Gualillo O. Mediators of inflammation in obesity and its comorbidities. Hindawi; 2010;2010:239126.","DOI":"10.1155\/2010\/239126"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101715_bib0057","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in obesity: mechanisms and potential targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.cpcardiol.2023.101715_bib0058","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Piche","year":"2020","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.cpcardiol.2023.101715_bib0059","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cpcardiol.2023.101715_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1874192401105010041","article-title":"Dyslipidemia associated with chronic kidney disease","volume":"5","author":"Tsimihodimos","year":"2011","journal-title":"Open Cardiovasc Med J"},{"issue":"15","key":"10.1016\/j.cpcardiol.2023.101715_bib0061","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101715_bib0062","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11892-021-01442-z","article-title":"Renal protection with SGLT2 inhibitors: effects in acute and chronic kidney disease","volume":"22","author":"Bailey","year":"2022","journal-title":"Curr Diab Rep"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623001329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623001329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:20:10Z","timestamp":1758939610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623001329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0146280623001329"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101715","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the Underlying Mechanisms Linking Adiposity and Cardiovascular Disease: A Prospective Cohort Study of 404,332 UK Biobank Participants","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101715"}}